T-cell phenotype is associated with decreased survival in non-Hodgkin's lymphoma

Japanese Journal of Cancer Research : Gann
K ShimizuA Kunii

Abstract

This study was undertaken to determine which if any pretreatment factors are statistically significant determinants of the clinical outcome in patients with non-Hodgkin's lymphoma. The pretreatment factors in 20 patients with T-cell lymphoma, including two patients with adult T-cell leukemia/lymphoma (ATLL), and 28 patients with B-cell lymphoma were evaluated. In a stepwise logistic regression analysis, a T-cell phenotype in addition to high grade histology and pleural involvement demonstrated a statistically significant correlation with decreased response rate, when the analysis did not include patients with ATLL. Analysis by means of the Cox proportional hazards model disclosed that the T-cell phenotype retained a statistically significant correlation with survival after adjustments for other prognostic factors, whether the study included the patients with ATLL or not. The decreased response rate and survival of Japanese patients with non-Hodgkin's lymphoma in comparison with those reported in Western countries seem to be due to increased intrusion of T-cell lymphomas. To permit a reliable comparison of reports on new chemotherapeutic regimens from different institutions, the tumor phenotype must be determined in the populati...Continue Reading

References

Jul 1, 1985·Annals of Internal Medicine·M Coleman
May 1, 1985·Annals of Internal Medicine·P Klimo, J M Connors
Jun 1, 1989·American Journal of Clinical Oncology·K ShimizuA Kunii
Jan 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M ShimoyamaS Tominaga
Jul 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M ShimoyamaK Minato
Mar 1, 1985·American Journal of Clinical Pathology·T M GroganS Jones
Oct 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B CoiffierJ P Magaud
Sep 1, 1986·American Journal of Clinical Pathology·K ShimizuA Kunii
Jul 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J P GreerR S Stein
Jan 1, 1982·International Urology and Nephrology·J SzöllösiM Sas

❮ Previous
Next ❯

Citations

Jan 1, 1991·Leukemia & Lymphoma·D M MtasiwaA Kuramoto
Jan 1, 1991·Leukemia Research·P M ChenT J Chiou
May 1, 1992·Hematological Oncology·R LiangA C Chan
May 1, 1992·Hematological Oncology·R LiangS L Loke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

[Rinshō ketsueki] The Japanese journal of clinical hematology
K KinoshitaY Yamada
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
M ShimoyamaK Minato
[Rinshō ketsueki] The Japanese journal of clinical hematology
Koji Kato
© 2022 Meta ULC. All rights reserved